Green Cross Japan Bio Products

Japan Bio Products (JBP) is a prominent Japanese biotechnology and pharmaceutical company specializing in the development and manufacture of placenta-derived products. Founded in 1954, the company is globally recognized for its flagship product, Laennec, a human placenta extract approved in Japan for the treatment of liver cirrhosis and menopausal symptoms. JBP utilizes proprietary molecular weight fractionation and high-pressure steam sterilization technologies to produce high-quality biological extracts used in pharmaceuticals, cosmetics, and dietary supplements. In addition to its core placenta business, the company manufactures specialized medical devices, such as the JBP Nanoneedle, designed for minimally invasive injections. Headquartered in Tokyo with manufacturing facilities in Fukuoka, JBP maintains extensive international operations and partnerships, particularly with GC Biopharma in South Korea.